131 related articles for article (PubMed ID: 37315400)
1. SOX9/NFIA promotes human ovarian cancer metastasis through the Wnt/β-catenin signaling pathway.
Lu R; Tang P; Zhang D; Lin S; Li H; Feng X; Sun M; Zhang H
Pathol Res Pract; 2023 Aug; 248():154602. PubMed ID: 37315400
[TBL] [Abstract][Full Text] [Related]
2. SOX9 drives the epithelial-mesenchymal transition in non-small-cell lung cancer through the Wnt/β-catenin pathway.
Huang JQ; Wei FK; Xu XL; Ye SX; Song JW; Ding PK; Zhu J; Li HF; Luo XP; Gong H; Su L; Yang L; Gong LY
J Transl Med; 2019 May; 17(1):143. PubMed ID: 31060551
[TBL] [Abstract][Full Text] [Related]
3. Sex determining region Y-box 9 induced microtubule formation and epithelial⁃mesenchymal transition in human oral squamous cell carcinoma CAL27 cells.
Huang S; Zhang QY; He AE; Li HB; Zhang ZX
Hua Xi Kou Qiang Yi Xue Za Zhi; 2021 Feb; 39(1):74-80. PubMed ID: 33723940
[TBL] [Abstract][Full Text] [Related]
4. SOX9 Overexpression Promotes Glioma Metastasis via Wnt/β-Catenin Signaling.
Liu H; Liu Z; Jiang B; Peng R; Ma Z; Lu J
Cell Biochem Biophys; 2015 Sep; 73(1):205-12. PubMed ID: 25716338
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of FOXC1 Promotes Tumor Metastasis by Activating the Wnt/β-Catenin Signaling Pathway in Gastric Cancer.
Sun Y; Lin C; Ding Q; Dai Y
Dig Dis Sci; 2022 Aug; 67(8):3742-3752. PubMed ID: 34427817
[TBL] [Abstract][Full Text] [Related]
6. Odd-skipped related 1 inhibits lung cancer proliferation and invasion by reducing Wnt signaling through the suppression of SOX9 and β-catenin.
Wang Y; Lei L; Zheng YW; Zhang L; Li ZH; Shen HY; Jiang GY; Zhang XP; Wang EH; Xu HT
Cancer Sci; 2018 Jun; 109(6):1799-1810. PubMed ID: 29660200
[TBL] [Abstract][Full Text] [Related]
7. CUL4B promotes metastasis and proliferation in pancreatic cancer cells by inducing epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway.
He YM; Xiao YS; Wei L; Zhang JQ; Peng CH
J Cell Biochem; 2018 Jul; 119(7):5308-5323. PubMed ID: 29274277
[TBL] [Abstract][Full Text] [Related]
8. Dexmedetomidine upregulates microRNA-185 to suppress ovarian cancer growth via inhibiting the SOX9/Wnt/β-catenin signaling pathway.
Tian H; Hou L; Xiong Y; Cheng Q
Cell Cycle; 2021 Apr; 20(8):765-780. PubMed ID: 33818283
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-506 inhibits tumor growth and metastasis in nasopharyngeal carcinoma through the inactivation of the Wnt/β-catenin signaling pathway by down-regulating LHX2.
Liang TS; Zheng YJ; Wang J; Zhao JY; Yang DK; Liu ZS
J Exp Clin Cancer Res; 2019 Feb; 38(1):97. PubMed ID: 30791932
[TBL] [Abstract][Full Text] [Related]
10. The role of nuclear β-catenin accumulation in the Twist2-induced ovarian cancer EMT.
Mao Y; Xu J; Li Z; Zhang N; Yin H; Liu Z
PLoS One; 2013; 8(11):e78200. PubMed ID: 24244294
[TBL] [Abstract][Full Text] [Related]
11. EphA2 promotes epithelial-mesenchymal transition through the Wnt/β-catenin pathway in gastric cancer cells.
Huang J; Xiao D; Li G; Ma J; Chen P; Yuan W; Hou F; Ge J; Zhong M; Tang Y; Xia X; Chen Z
Oncogene; 2014 May; 33(21):2737-47. PubMed ID: 23752181
[TBL] [Abstract][Full Text] [Related]
12. BRMS1L suppresses ovarian cancer metastasis via inhibition of the β-catenin-wnt pathway.
Cao P; Zhao S; Sun Z; Jiang N; Shang Y; Wang Y; Gu J; Li S
Exp Cell Res; 2018 Oct; 371(1):214-221. PubMed ID: 30118697
[TBL] [Abstract][Full Text] [Related]
13. FERMT1 mediates epithelial-mesenchymal transition to promote colon cancer metastasis via modulation of β-catenin transcriptional activity.
Liu CC; Cai DL; Sun F; Wu ZH; Yue B; Zhao SL; Wu XS; Zhang M; Zhu XW; Peng ZH; Yan DW
Oncogene; 2017 Mar; 36(13):1779-1792. PubMed ID: 27641329
[TBL] [Abstract][Full Text] [Related]
14. SOX9 regulated proliferation and apoptosis of human lung carcinoma cells by the Wnt/β-catenin signaling pathway.
Guo YZ; Xie XL; Fu J; Xing GL
Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4898-4907. PubMed ID: 30070325
[TBL] [Abstract][Full Text] [Related]
15. MiR-1207 overexpression promotes cancer stem cell-like traits in ovarian cancer by activating the Wnt/β-catenin signaling pathway.
Wu G; Liu A; Zhu J; Lei F; Wu S; Zhang X; Ye L; Cao L; He S
Oncotarget; 2015 Oct; 6(30):28882-94. PubMed ID: 26337084
[TBL] [Abstract][Full Text] [Related]
16. Reduced expression of FILIP1L, a novel WNT pathway inhibitor, is associated with poor survival, progression and chemoresistance in ovarian cancer.
Kwon M; Kim JH; Rybak Y; Luna A; Choi CH; Chung JY; Hewitt SM; Adem A; Tubridy E; Lin J; Libutti SK
Oncotarget; 2016 Nov; 7(47):77052-77070. PubMed ID: 27776341
[TBL] [Abstract][Full Text] [Related]
17. Claudin-7 deficiency promotes stemness properties in colorectal cancer through Sox9-mediated Wnt/β-catenin signalling.
Xu C; Ding YH; Wang K; Hao M; Li H; Ding L
J Transl Med; 2021 Jul; 19(1):311. PubMed ID: 34281572
[TBL] [Abstract][Full Text] [Related]
18. SOX9 regulates low density lipoprotein receptor-related protein 6 (LRP6) and T-cell factor 4 (TCF4) expression and Wnt/β-catenin activation in breast cancer.
Wang H; He L; Ma F; Regan MM; Balk SP; Richardson AL; Yuan X
J Biol Chem; 2013 Mar; 288(9):6478-87. PubMed ID: 23306204
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-590-5p functions as a tumor suppressor in breast cancer conferring inhibitory effects on cell migration, invasion, and epithelial-mesenchymal transition by downregulating the Wnt-β-catenin signaling pathway.
Gao J; Yu SR; Yuan Y; Zhang LL; Lu JW; Feng JF; Hu SN
J Cell Physiol; 2019 Feb; 234(2):1827-1841. PubMed ID: 30191949
[TBL] [Abstract][Full Text] [Related]
20. Disheveled3 enhanced EMT and cancer stem-like cells properties via Wnt/β-catenin/c-Myc/SOX2 pathway in colorectal cancer.
Li Z; Yang Z; Liu W; Zhu W; Yin L; Han Z; Xian Y; Wen J; Tang H; Lin X; Yang Y; Wang J; Zhang K
J Transl Med; 2023 May; 21(1):302. PubMed ID: 37147666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
